Episode 251: Psychedelics + Neuroscience + Symposium, Panel

his week, Shane interviews nine Psychedelic Scholars and Enthusiasts recorded live from the Psychedelic Symposium at The University of Michigan. They discuss Psychedelic Therapy, DMT, Consciousness and Neuroscience. 

The views expressed do not necessarily reflect the views of The University of Michigan. 

Psychedelic Therapy and History

Rick Doblin, PhD, Executive Director

Multidisciplinary Association for Psychedelic Studies (MAPS)

Chair of the Board of Directors 

MAPS Public Benefit Corporation

Alan K. Davis, PhD

Licensed Psychologist and Assistant Professor

College of Social Work, The Ohio State University

Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University

Nick Denomme, PhD Candidate

Department of Pharmacology, Center for Consciousness Science, University of Michigan 

DMT and Consciousness

Chris Timmermann, PhD Candidate

Centre for Psychedelic Research Group, Imperial College London

Jon Dean, PhD Candidate

Department of Molecular and Integrative Physiology, Center for Consciousness Science, University of Michigan 

Nick Glynos, PhD Candidate

Department of Molecular and Integrative Physiology, Center for Consciousness Science, University of Michigan 

Psychedelic Neuroscience: Salvia, Ketamine, LSD

Katrin Preller, PhD

University of Zurich 

Yale University

Michael Brito, PhD Candidate

Department of Neuroscience, Center for Consciousness Science

University of Michigan 

Emma Trammel, PhD Candidate

Department of Neuroscience, Center for Consciousness Science

University of Michigan